Related Experiment Video
Updated: Jun 8, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Does atrial fibrillation affect plasma endothelin level?
Beata Wozakowska-Kapłon1, Radosław Bartkowiak, Grazyna Janiszewska
11st Clinical Department of Cardiology, Swietokrzyskie Centre of Cardiology, Kielce, Poland. bw.kaplon@poczta.onet.pl
Insights
Persistent atrial fibrillation (AF) does not alter endothelin-1 (ET-1) levels in patients without heart failure. Cardioversion also showed no significant impact on ET-1 concentrations.
Area of Science:
- Cardiology
- Vascular Biology
- Biochemistry
Background:
- Atrial fibrillation (AF) is linked to endothelial dysfunction.
- Endothelin-1 (ET-1) is a key mediator of vascular tone and function.
- Investigating ET-1 in AF may reveal insights into cardiovascular pathophysiology.
Purpose of the Study:
- To measure plasma ET-1 concentrations in persistent AF patients.
- To assess ET-1 levels after restoring sinus rhythm via cardioversion.
- To determine if ET-1 predicts rhythm maintenance post-cardioversion.
Main Methods:
- Study included 43 patients with persistent AF and normal left ventricular systolic function.
- Blood samples collected 24 hours before and 24 hours after cardioversion.
- Sinus rhythm maintenance assessed at 30 days post-cardioversion.
Main Results:
- No significant difference in ET-1 levels between AF patients and controls.
- Plasma ET-1 levels remained unchanged 24 hours post-cardioversion.
- No correlation found between baseline ET-1 and 30-day rhythm maintenance.
Conclusions:
- Persistent AF does not alter plasma ET-1 in patients with preserved LV function and no heart failure symptoms.
- Cardioversion does not significantly change plasma ET-1 levels within 24 hours.
- ET-1 is not a significant predictor of rhythm maintenance in this patient cohort.
Background:
Atrial fibrillation (AF) may result in endocardial endothelium dysfunction. The main objective of the study was to evaluate the plasma concentration of endothelin-1 (ET-1) during persistent AF and after sinus rhythm recovery following direct-current cardioversion and to assess the predictive value of ET-1 in AF patients.
Methods:
The study group consisted of 43 patients with persistent AF and normal left ventricle systolic function who had undergone successful cardioversion. Blood samples were collected twice: 24 hours before and 24 hours after cardioversion. All patients were also examined in terms of sinus rhythm maintenance on the 30th day after cardioversion.
Results:
There were no differences in ET-1 plasma concentration between the persistent AF group and the control group (2.6 ± 2.9 fmol/mL vs 2.3 ± 4.5 fmol/mL, NS). Plasma ET-1 levels did not change within 24 hours after successful cardioversion (2.5 ± 2.8 fmol/mL vs 2.6 ± 2.9 fmol/mL, NS). There was no correlation between the baseline plasma levels of ET-1 in patients with persistent AF and sinus rhythm maintenance 30 days after cardioversion.
Conclusions:
Persistent AF does not affect plasma ET-1 concentration in patients with normal left ventricle systolic function and with no symptoms of heart failure. There are no significant changes in plasma ET-1 level during the 24 hours after cardioversion.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Intracellular Signaling Affects Focal Adhesions
Some...
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Venous Thrombosis I: Introduction
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

